PRIMECAP MANAGEMENT CO/CA/ - MEREO BIOPHARMA GROUP PLC ownership

MEREO BIOPHARMA GROUP PLC's ticker is MREO and the CUSIP is 589492107. A total of 66 filers reported holding MEREO BIOPHARMA GROUP PLC in Q2 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.

Quarter-by-quarter ownership
PRIMECAP MANAGEMENT CO/CA/ ownership history of MEREO BIOPHARMA GROUP PLC
ValueSharesWeighting
Q3 2023$101,910
-51.0%
79,000
-49.9%
0.00%
Q2 2023$208,164
-0.7%
157,700
-46.8%
0.00%
Q1 2023$209,617
-6.0%
296,530
-0.2%
0.00%
Q4 2022$222,922
-17.7%
297,230
-5.6%
0.00%
Q3 2022$271,000
-24.7%
314,760
-2.1%
0.00%
Q2 2022$360,000
-3.0%
321,660
-2.8%
0.00%
Q1 2022$371,000
-30.3%
330,900
-0.4%
0.00%
Q4 2021$532,000
-35.3%
332,200
-2.2%
0.00%
-100.0%
Q3 2021$822,000
-47.0%
339,600
-30.5%
0.00%0.0%
Q2 2021$1,550,000
-5.9%
488,938
-0.0%
0.00%0.0%
Q1 2021$1,648,000
-5.9%
489,1000.0%0.00%0.0%
Q4 2020$1,751,000
+36.7%
489,1000.0%0.00%0.0%
Q3 2020$1,281,000
-14.4%
489,1000.0%0.00%0.0%
Q2 2020$1,497,000
+167.3%
489,100
-10.0%
0.00%0.0%
Q1 2020$560,000
-71.6%
543,375
-9.7%
0.00%0.0%
Q4 2019$1,974,000
-0.4%
601,762
-11.9%
0.00%
-50.0%
Q3 2019$1,982,000
+18.6%
683,356
-1.8%
0.00%
+100.0%
Q2 2019$1,671,000696,1100.00%
Other shareholders
MEREO BIOPHARMA GROUP PLC shareholders Q2 2022
NameSharesValueWeighting ↓
COMMODORE CAPITAL LP 1,854,278$6,638,0003.61%
Asymmetry Capital Management, L.P. 739,812$2,649,0001.21%
Affinity Asset Advisors, LLC 625,000$2,238,0001.19%
Tri Locum Partners LP 728,710$2,609,0000.95%
Boxer Capital, LLC 6,226,673$22,291,0000.72%
DAFNA Capital Management LLC 668,148$2,392,0000.71%
Vivo Capital, LLC 4,220,938$15,111,0000.67%
Delphi Management Partners VIII, L.L.C. 256,734$919,0000.60%
SILVERARC CAPITAL MANAGEMENT, LLC 280,000$1,002,0000.58%
Rubric Capital Management LP 1,853,417$6,635,0000.49%
View complete list of MEREO BIOPHARMA GROUP PLC shareholders